These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3509172)

  • 21. [Treatment of hyperprolactinemic conditions with bromoergocryptine].
    Sas M; Godó G; Morvay J
    Zentralbl Gynakol; 1978; 100(22):1501-7. PubMed ID: 570784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Intermittent administration of bromocriptine in the treatment of amenorrhea-galactorrhea syndrome].
    Hartemann P; Leclere J; Groussin M; Mizrahi R
    Nouv Presse Med; 1977 Oct; 6(34):3111. PubMed ID: 562510
    [No Abstract]   [Full Text] [Related]  

  • 23. Restoration of ovarian function by low nocturnal single daily doses of bromocriptine in patients with the galactorrhea-amenorrhea syndrome.
    de Bernal M; de Villamizar M
    Fertil Steril; 1982 Mar; 37(3):392-6. PubMed ID: 6800849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of bromocriptine as a diagnostic and therapeutic tool in hyperprolactinemic states.
    Abraham G
    Prog Clin Biol Res; 1982; 112 Pt A():255-73. PubMed ID: 7163300
    [No Abstract]   [Full Text] [Related]  

  • 25. [2-bromo-alpha-ergocryptine in the treatment of luteal insufficiency].
    Nappi C; Votino F; Mattera P; Montemagno U
    Minerva Ginecol; 1979 Apr; 31(4):273-80. PubMed ID: 572516
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of bromo-ergocryptine on serum hPRL, hLH, hFSH, and estradiol 17-beta in women with galactorrhea-amenorrhea.
    Dickey RP; Stone SC
    Obstet Gynecol; 1976 Jul; 48(1):84-9. PubMed ID: 934580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ineffectiveness of pyridoxine (B6) to alter secretion of growth hormone and prolactin and absence of therapeutic effects on galactorrhea-amenorrhea syndromes.
    Tolis G; Laliberté R; Guyda H; Naftolin F
    J Clin Endocrinol Metab; 1977 Jun; 44(6):1197-9. PubMed ID: 559690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Results of treatment of galactorrhea-amenorrhea syndrome with bromocryptine (Parlodel)].
    Dudkiewicz J; Blecharz A; Kosowicz J
    Endokrynol Pol; 1978; 29(3):181-90. PubMed ID: 566660
    [No Abstract]   [Full Text] [Related]  

  • 29. The treatment with 2-brom-alfa ergocriptine in the syndrome amenorrhea-galactorrhea.
    Sirbu P; Cioltei A; Simionescu L; Dumbravescu A; Sedan E; Titiriga L; Mîtulescu V
    Acta Eur Fertil; 1979 Dec; 10(4):177. PubMed ID: 552769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evolution of 15 pregnancies induced with bromocriptine therapy in patients with amenorrhea-galactorrhea].
    Campagnoli C; Belforte L; Bruno M; Fessia L; Pinna N; Massara F
    Minerva Ginecol; 1980 May; 32(5):400-4. PubMed ID: 7393487
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of the galactorrhea and amenorrhea syndrome associated with acromegaly using 2-bromine-alpha-ergocryptine].
    Durić DS; Dordević PB; Mićić JV; Popović SS
    Srp Arh Celok Lek; 1977 Feb; 105(2):179-89. PubMed ID: 562001
    [No Abstract]   [Full Text] [Related]  

  • 32. Ovarian refractoriness to gonadotropins in cases of inappropriate lactation: restoration of ovarian function with bromocryptine.
    Mroueh AM; Siler-Khodr TM
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1398-401. PubMed ID: 1036743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Results of the clinical use of Parlodel in the galactorrhea-amenorrhea syndrome and in acromegaly].
    Starkova NT; Mel'nichenko GA; Pronin VS
    Sov Med; 1978 Jun; (6):88-91. PubMed ID: 354025
    [No Abstract]   [Full Text] [Related]  

  • 34. [Successful treatment of galactorrhea, anemorrhea and infertility with a new ergot alkaloid (2-Br-alpha-ergocryptine)].
    Schellekens LA; Roland R; Lequin RM
    Ned Tijdschr Geneeskd; 1975 Apr; 119(14):541-7. PubMed ID: 1170514
    [No Abstract]   [Full Text] [Related]  

  • 35. Cyproheptadine in the management of the galactorrhea-amenorrhea syndrome.
    Wortsman J; Soler NG; Hirschowitz J
    Ann Intern Med; 1979 Jun; 90(6):923-5. PubMed ID: 571691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of acute parlodel load on the prolactin and STH content in patients with various neuroendocrine diseases].
    Mel'nichenko GA; Bol'shakova TD; Gitel' EP; Langner TK; Barkova MV
    Probl Endokrinol (Mosk); 1983; 29(1):19-23. PubMed ID: 6682222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of women with the galactorrhea-amenorrhea syndrome with pyridoxine (vitamin B6).
    McIntosh EN
    J Clin Endocrinol Metab; 1976 Jun; 42(6):1192-5. PubMed ID: 945301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pregnancy with thyroid replacement and additional bromocriptine therapy in a patient of amenorrhea-galactorrhea syndrome due to primary hypothyroidism (author's transl)].
    Matsuura K; Mizumoto J; Maeyama M
    Acta Obstet Gynaecol Jpn; 1981 Feb; 33(2):305-8. PubMed ID: 7234339
    [No Abstract]   [Full Text] [Related]  

  • 39. Bromocryptine therapy in cases of amenorrhea-galactorrhea.
    Mroueh AM; Siler-Khodr TM
    Am J Obstet Gynecol; 1977 Feb; 127(3):291-8. PubMed ID: 576372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Longtime study on bromoergocryptine therapy and pyridoxine therapy of amenorrhea-galactorrhea].
    Schindler AE; Plieninger M; Zubke W; Göser R; Keller E
    Arch Gynecol; 1979 Jul; 228(1-4):596. PubMed ID: 573598
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.